(Reuters) – A federal judge on Tuesday questioned why he would approve a $ 2 billion proposal from Bayer AG that would create a framework for resolving future allegations that the company's Roundup herbicides cause cancer, doubting a day before A Key Inquiry
Bayer and group speakers hope that U.S. District Judge Vince Chhabria in San Francisco will give preliminary approval on Wednesday for a settlement that would create a compensation fund for people who become ill in the future from exposure to Roundup.
The company has said that decades of studies have shown that Roundup and its active ingredient glyphosate do not cause cancer and are safe for human use.
Consumer groups and personal injury lawyers have criticized the plan, which also prevents Roundup users. who gets non-Hodgkin's lymphoma from suing for four years and prevents them from claiming damages from Bayer.
Judge Chhabria asked in court if it was possible to contact the potentially millions of homeowners and farm workers who have been subjected to Roundup to inform them that they will be bound by the settlement. plan against other alternatives, including Bayer adding a cancer warning label to Roundup, something the company has opposed. 1
Bayer inherited the glyphosate-based herbicide Roundup and the disputes as part of a $ 63 billion acquisition of Monsanto in 2018.